Colon to Rectum

N Engl J Med. 2025;393(1):13-25

Courneya KS, Vardy JL, O’Callaghan CJ, Gill S, Friedenreich CM, Wong RKS, Dhillon HM, Coyle V, Chua NS, Jonker DJ, Beale PJ, Haider K, Tang PA, Bonaventura T, Wong R, Lim HJ, Burge ME, Hubay S, Sanatani M, Campbell KL, Arthuso FZ, Turner J, Meyer RM, Brundage M, O’Brien P, Tu D, Booth CM; CHALLENGE Investigators

Structured exercise after adjuvant chemotherapy for colon cancer


Background: Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence is lacking.
Methods: The phase 3, randomized trial conducted at 55 centers assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured exercise program (exercise group) or to receive health-education materials alone (health-education group) over a 3-year period. The primary end point was disease-free survival.
Results: From 2009 through 2024, a total of 889 patients underwent randomization to the exercise group (445 patients) or the health-education group (444 patients). At a median follow-up of 7.9 years, disease-free survival was significantly longer in the exercise group than in the health-education group (hazard ratio [HR] for disease recurrence, new primary cancer, or death, 0.72; 95% confidence interval [CI]: 0.55–0.94; p = 0.02). The 5-year disease-free survival was 80.3% in the exercise group and 73.9% in the health-education group (difference, 6.4 percentage points; 95% CI: 0.6–12.2). Results support longer overall survival in the exercise group than in the health-education group (HR for death, 0.63; 95% CI: 0.43–0.94). The 8-year overall survival was 90.3% in the exercise group and 83.2% in the health-education group (difference, 7.1 percentage points; 95% CI: 1.8–12.3). Musculoskeletal adverse events occurred more often in the exercise group than in the health-education group (in 18.5% vs. 11.5% of patients).

Conclusions: A 3-year structured exercise program initiated soon after adjuvant chemotherapy for colon cancer resulted in significantly longer disease-free survival and findings consistent with longer overall survival.

K.S. Courneya, Faculty of Kinesiology, Sport, and Recreation, College of Health Sciences, University of Alberta, Edmonton, AB, Canada, e-mail: kerry.courneya@ualberta.ca

or

C.M. Booth, Department of Oncology, Queen’s University, Kingston, ON, Canada, e-mail: booth@queensu.ca

DOI:  10.1056/nejmoa2502760

Back to overview

this could be of interest:

Colon to Rectum

Nonoperative management of mismatch repair-deficient tumors

N Engl J Med. 2025;392(23):2297-2308

More articles on the topic